Robert K. Naviaux, MD, PhD, Professor of Genetics, Biochemical Genetics and Metabolism, Departments of Medicine, Pediatrics, and Pathology Co-director, The Mitochondrial and Metabolic Disease Center (MMDC) UCSD School of Medicine: Antipurinergic Therapy to Address Core Disabilities of ASD

Sarkis Mazmanian, PhD, Luis B. and Nelly Soux Professor of Microbiology, California Institute of Technology: The Microbiome and Autism – Basic Research to Clinical Trials

James Adams PhD, President’s Professor, Director of Autism/Asperger’s Research Program & Rosa Krajmalnik-Brown Phd, Arizona State University, US: Microbiota Transfer Therapy for Children with ASD and GI Disorders: Summary of Phase 1 and Follow-Up

Dr. Michael Merzenich, Professor Emeritus, UCSF, Kavli Laureate in Neuroscience, CSO Posit Science Corporation, CSO Stronger Brains: Brain Plasticity in Autism Spectrum Disorder

David Bick MD, SCO and Faculty Investigator at HudsonAlpha Institute for Biotechnology: Genomic Testing in Autism Spectrum Disorder

Daniel Rossignol, MD, FAAFP, Rossignol Medical Center: A New Evidence-Based Method for Choosing the Most Effective Treatments for Autism

Ronald W. Davis, PhD, Professor of Biochemistry & Genetics, Director of the Stanford Genome Technology Center at Stanford University: The End ME/CFS Project

Dennis Dixon, PhD, Chief Clinical Officer, Center for Autism and Related Disorders: Collaborative Care in ABA Treatment for Autism

Edward Quadros, PhD, Professor, Department of Cell Biology, SUNY Downstate Health Sciences University: Disruption of Brain Development and Function by Folate Receptor Antibodies: Treatment of Autism Spectrum Disorders

Richard Boles, MD, Harvard Medical School: Mitochondrial Medicine and Autism

RICHARD FRYE, MD, PHD, Phoenix Children’s Hospital and University of Arizona College of Medicine-Phoenix: Seizures and Epilepsy in Autism Spectrum Disorder

Arthur Krigsman MD, Pediatric Gastroenterologist, Private Practice, New York: Autism-Associated Enterocolitis Treatment Study